BMS-1001

CAS : 2113650-03-4

Ref. 3D-NJD65003

Informations sur le produit

• Nom: BMS-1001

Description

BMS-1001 is a monoclonal antibody that targets the death protein (DR5). DR5 is an oncogenic receptor that binds to the tumor necrosis factor receptor 1 (TNFR1) and activates NF-κB signaling. The activation of TNFR1 induces the production of proinflammatory cytokines, which contribute to the development of cancer. BMS-1001 has been shown to inhibit tumor growth in animal models by inhibiting TNFR1 signaling, without inducing any adverse effects. It has also been shown to induce tumor regression in patients with metastatic melanoma, prostate cancer, and lung cancer. In addition, BMS-1001 has been shown to be active against other types of cancers such as pancreatic cancer, colorectal cancer, and glioblastoma

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 594.65 g/mol
• Formule: C₃₅H₃₄N₂O₇
• Degré de pureté: Min. 95%